Requip XL 2 mg
Available Dosages
| SKU | 892 |
|---|---|
| Generic For | Requip |
| Strength | 2 mg |
| Manufacturer | GSK, Spain |
| Active Ingredient | Ropinirole Hydrobromide |
Out Of Stock
Requip XL 2 mg (Ropinirole Hydrobromide)
Requip xl 2 mg (Ropinirole)
Requip XL medicine contains the active ingredient Ropinirole, which is included among the class of dopamine agonists. This drug is widely used to treat Parkinson's disease and restless legs syndrome (RLS). It can replace dopamine, a natural substance in the brain that helps you control nerve to control body movement. It comes in an oral standard and an extended-release tablet. This drug is manufactured by GlaxoSmithKline and approved by the Food and Drug Administration (FDA) in 2008.
What is Requip XL used for?
Requip XL 2 mg is prescribed to treat Parkinson’s disease. This medicine should be taken under prescription, and it may harm you if you have no signs of illness. It’s easy to switch patients from Ropinirole immediate release tablets to Ropinirole prolonged-release tablets.
How does Requip XL work?
The active ingredient of Requip XL 2 mg, Ropinirole belongs to a group of medicines called dopamine agonists that can affect the brain’s natural substance called dopamine. Low level of dopamine raises the risks of Parkinson’s disease, and Ropinirole has similar effects like dopamine. Requip XL should be taken under a doctor’s prescription and its progress should be monitored regularly.
What does Requip XL contain?
Each extended release tablet contains 2 mg of the active component Ropinirole.
What are the side effects of Requip XL?
There are some common side effects of Requip XL, such as:
- Inability to control your impulse, drive or temptation to perform an action
- Strong impulse
- Short temper and eagerness to gamble excessively
- Decreased sensitivity to touch
- Frequent or urgent need to urinate
- Altered or increased sexual interest and behavior of significant concern to you or to others
- Fever, stiff muscles, confusion, sweating, fast or uneven heartbeats
- Uncontrollable excessive shopping or spending
- Eating disorder or taking large amounts of food in a short time period
- Swelling in your hands, arms, feet, ankles, or lower legs
- Disturbance in appetite
Some rare side effects of Requip XL include:
- Feeling dizzy or faint, especially when you stand up suddenly (this is caused by a drop in blood pressure)
- Drowsiness or falling asleep very suddenly without feeling sleepy first (sudden sleep onset episodes)
- Mental or psychological problems such as delirium (severe confusion), delusions (unreasonable ideas) or paranoia (unreasonable suspicions).
What medications interact with Requip XL?
There are some drugs or medicinal elements that may interact with Requp XL 2 mg. These medications include:
- Kava
- Antipsychotic medications like chlorpromazine, haloperidol, thiothixene
- Any antidepressants
- Warfarin (Coumadin)
- Metoclopramide
- Ciprofloxacin (Cipro)
Tell your doctor about all prescription, non-prescription, illegal, recreational, herbal, nutritional, or dietary drugs that you are taking along with Requip.
Some other medications are also there that can influence the effectiveness. These medications are , omeprazole, rifampin, cimetidine, fluvoxamine, mexiletine, drugs to treat seizures (such as carbamazepine, phenobarbital), etc.
When should Requip XL not be used?
These you already have some conditions, then talk to your doctor before taking Requip XL 2 mg. These conditions are:
- If you are breastfeeding
- If you have an intolerance to some sugars (such as lactose)
- If you are under 18 years old
- If you are pregnant or think you may be pregnant
- If you have a history of or have experienced any unusual urges and/or behaviors (such as excessive gambling or excessive sexual behavior
What is Requip XL 2mg used for?
Requip XL 2mg contains ropinirole 2mg in a 24-hour extended-release (XL) formulation. It is used for treating Parkinson's disease and restless legs syndrome (RLS). In Parkinson's disease, ropinirole XL is taken once daily to provide sustained dopamine receptor stimulation throughout the day, smoothing motor fluctuations. The 2mg XL dose is an intermediate dose used during titration from lower to higher doses, or as a maintenance dose in patients with early-moderate Parkinson's disease.
How does ropinirole XL work in Parkinson's disease?
Ropinirole is a non-ergot dopamine D2/D3 receptor agonist. It directly stimulates dopamine receptors in the striatum, mimicking the effects of dopamine that is deficient in Parkinson's disease. The XL (extended-release) formulation maintains stable plasma ropinirole levels over 24 hours, reducing the peaks and troughs associated with immediate-release formulations. Stable dopamine receptor stimulation reduces motor fluctuations and minimises wearing-off, dyskinesia, and on-off phenomena compared to immediate-release dopaminergic therapy.
How should Requip XL 2mg be taken?
Requip XL 2mg is taken once daily with or after the main meal to reduce nausea. Swallow the tablet whole — do not crush, chew, or split the extended-release tablet. Start at 2mg once daily and assess response after 1–2 weeks before considering dose increase to 4mg XL or higher. The maximum recommended dose of ropinirole XL for Parkinson's disease is 24mg/day. Consistent once-daily timing improves blood level stability. Do not abruptly stop ropinirole — taper gradually under medical supervision.
When is ropinirole XL used as monotherapy vs. with levodopa?
Ropinirole XL is used as monotherapy in early Parkinson's disease — particularly in younger patients (<70 years) where delaying levodopa therapy reduces long-term dyskinesia risk. As the disease progresses and dopamine cell loss increases, levodopa is added. Ropinirole XL as levodopa adjunct reduces daily 'off' time by approximately 2 hours, allowing levodopa dose reduction. The XL formulation is preferred over immediate-release for once-daily adherence and smoother motor control throughout the day.
Is Requip XL 2mg safe for elderly Parkinson's patients?
Ropinirole XL is used in elderly patients but requires care — dopamine agonists cause more orthostatic hypotension, hallucinations, and cognitive effects in the elderly than in younger patients. Impulse control disorders (gambling, hypersexuality, binge eating) are a documented side effect of dopamine agonists, requiring monitoring. Elderly patients often tolerate lower doses better and may not require titration to high ropinirole doses before adding levodopa instead. Falls risk from orthostatic hypotension warrants home safety assessment.
Who should not use ropinirole?
Ropinirole is contraindicated in known hypersensitivity. It should be used with caution in patients with significant psychiatric disorders (psychosis, hallucinations) as dopamine agonism can worsen these. Severe renal impairment (eGFR <30 ml/min) requires caution and dose adjustment. Abrupt discontinuation can cause neuroleptic malignant syndrome-like symptoms — always taper. Fluvoxamine significantly increases ropinirole levels (CYP1A2 inhibitor). Smoking cessation increases ropinirole exposure (CYP1A2 induced by smoking — stopping smoking requires dose review).
How does ropinirole XL compare to pramipexole ER for Parkinson's disease?
Both ropinirole XL and pramipexole ER are non-ergot dopamine agonists with once-daily extended-release formulations for Parkinson's disease. Both have similar efficacy and side effect profiles — orthostatic hypotension, nausea, hallucinations, and impulse control disorders. Differences are minor; choice is often based on local prescribing preference, drug interactions, and individual patient response. Pramipexole is renally excreted (dose adjust in CKD); ropinirole is hepatically metabolised. Patients who fail to respond to one dopamine agonist may respond to switching to the other.
Is Requip XL equivalent to branded Requip XL?
Yes. Requip XL 2mg tablets containing ropinirole 2mg XL are bioequivalent to branded Requip XL 2mg (GlaxoSmithKline). Both provide sustained 24-hour dopamine receptor stimulation with identical pharmacokinetics when manufactured to bioequivalence standards. Generic ropinirole XL provides significant cost savings for patients requiring long-term Parkinson's disease management.
Can I order Requip XL 2mg from PremiumRxDrugs for delivery to the UK?
Yes. PremiumRxDrugs.com ships Requip XL 2mg to the UK, USA, Australia, and many other countries. Our genuine manufacturer-verified Parkinson's medications, competitive pricing, and free worldwide shipping on qualifying orders make us a trusted international pharmacy for patients on dopamine agonist therapy.
What side effects does Requip XL 2mg cause?
Common: nausea, dizziness, somnolence (excessive sleepiness), and orthostatic hypotension — especially at dose initiation or increase. Sudden sleep attacks (falling asleep without warning) require caution when driving. Hallucinations and confusion occur particularly in elderly patients. Impulse control disorders (gambling, compulsive shopping, hypersexuality, binge eating) affect 10–20% of dopamine agonist users — screen at each review. Peripheral oedema and leg swelling are commonly reported with ropinirole.
What precautions are essential with Requip XL 2mg?
Never stop abruptly — taper gradually. Monitor for impulse control disorders at every clinic visit — ask directly as patients rarely volunteer this information. Warn patients about sudden sleep attacks — avoid driving until the individual response is established. Monitor blood pressure orthostatic measurements. Avoid fluvoxamine (CYP1A2 inhibitor that significantly increases ropinirole levels). If a patient quits smoking, review the ropinirole dose — smoking induces CYP1A2 and its cessation increases ropinirole exposure. Swallow XL tablet whole.
Login
Sign Up
Login
Sign Up